Security Snapshot

ARK ETF TR - GENOMIC REV ETF (ARKG) Institutional Ownership

CUSIP: 00214Q302

13F Institutional Holders and Ownership History from Q4 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

271

Shares (Excl. Options)

35,076,856

Price

$42.06

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+6,286,057
Value change
+$272,715,643
Number of holders
271
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$37.82
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ARKG - ARK ETF TR - GENOMIC REV ETF is tracked under CUSIP 00214Q302.
  • 271 institutions reported positions in Q2 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 220 to 271 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $742,710,860 to $1,477,575,264.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 271 institutions filings for Q2 2026.

Open SEC evidence

Security key

00214Q302

Latest holder period

Q2 2026

13F holders

271

13D/G owners

0

CIK / CUSIP context first

As of 30 Jun 2026, 271 institutional investors reported holding 35,076,856 shares of ARK ETF TR - GENOMIC REV ETF (ARKG).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
47
Latest
Q2 2026
Rows shown
1-25 of 47
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 35,076,856 $1,477,575,264 +$272,715,643 $42.06 271
2026 Q1 28,537,208 $742,710,860 +$24,351,123 $26.42 220
2025 Q4 29,459,581 $853,593,202 +$173,840,101 $28.97 239
2025 Q3 22,065,591 $613,098,185 +$21,472,540 $27.77 230
2025 Q2 21,611,541 $526,299,881 -$30,340,417 $24.35 208
2025 Q1 23,101,944 $479,673,052 -$55,581,611 $20.76 208
2024 Q4 24,359,584 $573,766,398 -$37,881,926 $23.54 233
2024 Q3 27,319,167 $699,250,691 +$92,150,396 $25.60 236
2024 Q2 22,697,563 $533,360,015 +$39,104,434 $23.48 255
2024 Q1 21,070,311 $605,869,850 +$29,425,107 $28.76 278
2023 Q4 18,854,497 $618,680,538 +$12,657,699 $32.81 295
2023 Q3 15,272,259 $424,908,985 -$83,636,429 $27.86 280
2023 Q2 19,519,789 $665,172,681 -$81,152,901 $34.09 285
2023 Q1 22,230,141 $668,316,409 +$77,890,388 $30.07 287
2022 Q4 18,500,202 $522,559,625 -$45,769,022 $28.23 308
2022 Q3 21,745,645 $714,574,611 +$11,094,001 $32.87 290
2022 Q2 19,759,934 $624,634,834 -$149,931,968 $31.49 311
2022 Q1 23,308,025 $1,070,074,056 +$44,471,414 $45.93 359
2021 Q4 22,717,723 $1,389,309,843 -$126,515,786 $61.24 440
2021 Q3 23,366,967 $1,745,726,599 -$180,784,054 $74.72 459
2021 Q2 25,659,492 $2,370,135,079 +$42,779,459 $92.50 505
2021 Q1 25,148,571 $2,232,467,554 +$479,464,342 $88.73 498
2020 Q4 19,547,660 $1,827,150,655 +$624,694,863 $93.26 406
2020 Q3 11,839,290 $755,235,763 +$171,057,097 $63.71 235
2020 Q2 9,170,973 $478,909,682 +$200,541,364 $52.16 162
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .